Barclays Starts MBX Biosciences Inc (MBX) at Overweight

January 27, 2026 4:34 PM EST Send to a Friend
Barclays analyst Eliana Merle initiates coverage on MBX Biosciences Inc (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login